Phase 2 Start~month

Phase 2 Start: PRE-surgical NEOadjuvant Sandwich Immunotherapy With HIF inhibiTion in Renal Cell Carcinoma (PRENEOS

Drug
hif
Indication
Renal Cell Carcinoma; Kidney Cancer; Kidney Neoplasm

Other upcoming events for RCUS

Patent ExpiryPatent/Exclusivity Expiry: ONMEL
Phase 3 ReadoutPhase 3 Topline: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chem
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib
Patent ExpiryPatent/Exclusivity Expiry: COMETRIQ
Patent ExpiryPatent/Exclusivity Expiry: STIVARGA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: PRE-surgical NEOadjuvant Sandwich Immunotherapy With HIF inhibiTion in Renal Cell Carcinoma (PRENEOS — RCUS Phase 2 Start | BioSniper